Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patient...
Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
•11–219 fewer indeterminate patients progressed, averting 6–120 deaths, 108–2229 DALYs.•10–197 fewer Kuschnir class 1 patients progressed, averting 11–228 deaths, 144–3037 DALYs.•13–279 fewer Kuschnir class 2 patients progressed, averting 13–692 deaths, 283–10,785 DALYs.•Vaccination saved ≤$16171 per indeterminate patient and ≤$89,759 per determina...
Alternative Titles
Full title
Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2232071639
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2232071639
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2019.05.028
